Another Roundup Trial Begins

An update this morning from The Economist Espresso daily Email stated that:

“When the German chemicals firm [Bayer] bought Monsanto, an American rival, for $63bn, it thought it had got a good deal. But Monsanto may have left Bayer with billions of dollars in liabilities given claims that Roundup, a weedkiller it makes, causes cancer. In August a California jury ruled in favour of a school groundskeeper who alleged that Roundup caused his non-Hodgkin’s lymphoma; it ordered the company to pay $289m in damages. Bayer, which denies that the weedkiller causes cancer, said the ruling would be overturned. But in October a judge at a state appeals court upheld the original verdict (while reducing the damages). Today another trial over Roundup, the first to take place in a federal court, begins in San Francisco. Around 8,700 similar cases targeting Monsanto are going through America’s legal system. It may not have been such a good deal after all.”

“Bayer’s remorse: Monsanto and Roundup,” The Economist Espresso Daily Email (February 25, 2019).

Also recall that Bloomberg News reported earlier this month that Monsanto also “faces a claim that it deceived home gardeners about Roundup’s impact on their gut bacteria and their health.”

This entry was posted in Agriculture Law. Bookmark the permalink. Both comments and trackbacks are currently closed.